Dehydroepiandrosterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs
Dehyroepiandrosterone (DHEA), an adrenal-derived steroid, has been clinically implicated in protection against coronary artery disease and experimentally in inhibition of atherosclerosis and plaque progression.